FDA Brief

Warning letters Drugs

FDA warning letter to

Dabur India Limited

High riskIssued Jul 24Posted Aug 4Center for Drug Evaluation and Research (CDER)

FDA cites Dabur India for falsified records, incomplete lab data, and inadequate cleaning and process validation for over-the-counter drugs.

What happened

During a January 12 to 16, 2026 inspection, FDA found that Dabur gave investigators a falsified equipment logbook and that reported batch record and test-report values did not match source data. FDA also found missing microbiology plates, missing test records for multiple U.S.-marketed batches, inadequate cleaning validation on shared equipment, and no process validation for many OTC drug products. After a May 13, 2026 teleconference, Dabur recalled some products on June 2, 2026, and FDA placed all its drugs on Import Alert 66-40 (an FDA import refusal list) on June 5, 2026.

What FDA found

  1. The quality control unit (the group responsible for quality decisions) did not have or use the authority to approve or reject materials and products and to review production records, and FDA found a falsified equipment logbook and reported values that did not match source data.

    21 CFR 211.22(a)
  2. Laboratory records were incomplete: microbiology and media plates recorded as incubated were missing, and test procedures or data could not be produced for multiple U.S.-marketed batches.

    21 CFR 211.194(a)
  3. Cleaning and maintenance procedures were inadequate because cleaning was checked only by looking, with no proven carryover limits, residue testing, or surface sampling, and one shared line had no cleaning validation.

    21 CFR 211.67(b)
  4. Production and process control procedures were inadequate because the firm had not validated (shown to consistently work) manufacturing processes for most OTC drug products.

    21 CFR 211.100(a)

What FDA wants

FDA asks Dabur to respond in writing within 15 working days with corrective actions and comprehensive assessments: documentation systems, quality-unit authority, data-integrity investigation, cleaning cross-contamination risk, and process validation plans and timelines. FDA also recommends an independent qualified consultant and may withhold approvals or refuse imports until corrections are confirmed.

Who should pay attention

  • U.S. distributors and retailers selling Dabur OTC drugs
  • contract manufacturers making multiple OTC products on shared equipment
  • quality and regulatory teams that rely on supplier lab records

This is a summary. Read the original letter on fda.gov.

Dabur India Limited's FDA history

Recalls in the last 12 months

Jun 24 Class II Dabur India Limited
Drug
Med Pride, HYDROCORTISONE CREAM 1%, Net Wt. 1 oz (28.3g) tubes, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 52410 30503 0.
CGMP Deviations; deficiencies observed during FDA inspection
Jun 24 Class II Dabur India Limited
Drug
Rapidol, Triple Antibiotic First Aid Ointment, Bacitracin Zinc 400 units, Neomycin Sulfate 3.5 mg, Polymyxin-B Sulfate 5,000 units, net wt. 2oz (57g) tubes, Distributed by/por: Pharmadel LLC, New Castle, DE 19720, Made i…
CGMP Deviations; deficiencies observed during FDA inspection
Jun 24 Class II Dabur India Limited
Drug
Med Pride, Triple Antibiotic Ointment, Bacitracin Zinc (equivalent to 400 units), Neomycin Sulfate 5 mg, Polymixin B 5000 units, 0.9g packets, 144 packets per box, 130g, Manufactured for: Shield Line LLC, 59 Hook Road, B…
CGMP Deviations; deficiencies observed during FDA inspection
Jun 24 Class II Dabur India Limited
Drug
Lucky Super Soft, First Aid Triple Antibiotic Ointment, Bacitracin zinc 400 units, neomycin sulphate 3.5 mg, polymyxin B sulphate 5000 units, Net Wt. 0.5 oz (14g) tubes, Manufactured for Delta Brands Inc., 580 White Plai…
CGMP Deviations; deficiencies observed during FDA inspection
Jun 24 Class II Dabur India Limited
Drug
Med Pride, Bacitracin Zinc Ointment, 1oz (28.3g) per tube, 72 tubes per case, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC X004WB4LKT.
CGMP Deviations; deficiencies observed during FDA inspection
Jun 24 Class II Dabur India Limited
Drug
Lucky Super Soft, Antifungal Athlete's Foot Cream, Clotrimazole 1% Cream, Net Wt. 1.5 oz (42.5g) Tubes, Manufactured for Delta Brands Inc., 580 White Plains Rd., Tarrytown, NY 10591 USA, Made in India, UPC 8 08829 10461 …
CGMP Deviations; deficiencies observed during FDA inspection
Jun 24 Class II Dabur India Limited
Drug
Med Pride, HYDROCORTISONE CREAM 1%, Net Wt. 16oz (454g) tubes, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 52410 305061.
CGMP Deviations; deficiencies observed during FDA inspection
Jun 24 Class II Dabur India Limited
Drug
Med Pride, Bacitracin Zinc Ointment, 500 units, 1oz (28.3g) tubes, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 52410 30354 8.
CGMP Deviations; deficiencies observed during FDA inspection
Jun 24 Class II Dabur India Limited
Drug
Lil Drug Store, Triple Antibiotic Ointment, Bacitracin Zinc (400 units), Neomycin Sulfate (3.5 mg), Polymyxin-B Sulfate (5000 units), net wt. 0.5 oz (14.2g), Product distributed by: Lil' Drug Store Products, Inc., 9300 E…
CGMP Deviations; deficiencies observed during FDA inspection
Jun 24 Class II Dabur India Limited
Drug
Med Pride, 1% Clotrimazole Antifungal Cream, Net Wt. 1oz (28.3g), Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 524103 0244 2.
CGMP Deviations; deficiencies observed during FDA inspection
Jun 24 Class II Dabur India Limited
Drug
Med Pride, Triple Antibiotic Ointment, Bacitracin Zinc 400 units, Neomycin Sulfate 5 mg, Polymyxin B 5000 units, 1oz (28.3g) tubes, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, U…
CGMP Deviations; deficiencies observed during FDA inspection
Jun 24 Class II Dabur India Limited
Drug
Circle K, triple antibiotic ointment, Bacitracin Zinc (400 units), Neomycin Sulfate (3.5 mg), Polymyxin-B Sulfate (5000 units), net wt. 0.5 oz (14.2g) tubes, Product manufactured for Lil' Drug Store Products, Inc., 9300 …
CGMP Deviations; deficiencies observed during FDA inspection
Jun 24 Class II Dabur India Limited
Drug
Cura Hongos, Crema Antifungica, Clotrimazole 1%, 2oz (57g) tubes, Dist by/por: Pharmadel LLC, New Castle, DE 19720, Made in India, UPC 8 52924 00683 1.
CGMP Deviations; deficiencies observed during FDA inspection
Jun 24 Class II Dabur India Limited
Drug
Med Pride, Bacitracin Zinc Ointment, 500 units, 0.9g packets Net Wt 130g, 144 count box, Manufactured for: Shield Line LLC, 59 Hook Road, Bayonne, NJ 07002 USA, Made in India, UPC 3 52410 30352 4.
CGMP Deviations; deficiencies observed during FDA inspection

Full company page

Similar letters to other companies

  1. Natural Essentials, Inc.

    FDA warns Natural Essentials over OTC drug manufacturing violations, including inadequate failing test result investigations and missing component identity tests.

    High risk
  2. Pritam International Private Limited

    Pritam International, an Indian OTC drug maker, was cited for CGMP violations, falsified lab data, unsafe color additive, and DEG/EG testing gaps.

    High risk
  3. Conroe Welding Supply, Inc.

    FDA warns Conroe Welding Supply over medical oxygen manufacturing failures, including untested batches and a container with 99% (b)(4).

    High risk
  4. SnugZ USA, Inc.

    SnugZ USA, an OTC drug maker in West Jordan, Utah, was cited for releasing drugs after retesting failed batches until they passed.

    High risk